CTNNB1 and Alzheimer disease: Interestingly, beta catenin 1 (Ctnnb1), part of the main pathway that regulates the onset and progression of AD [50], showed the largest increase in betweenness (from 0.0 to 27.3%, Fig. 7b) and became the main bottleneck in the AD network.